Kewaunee Scientific Corporation
KEQU · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Revenue | $240,472 | $203,755 | $219,494 | $168,872 |
| % Growth | 18% | -7.2% | 30% | – |
| Cost of Goods Sold | $171,615 | $151,704 | $183,906 | $144,652 |
| Gross Profit | $68,857 | $52,051 | $35,588 | $24,220 |
| % Margin | 28.6% | 25.5% | 16.2% | 14.3% |
| R&D Expenses | $0 | $920 | $1,012 | $990 |
| G&A Expenses | $50,186 | $37,611 | $29,706 | $26,625 |
| SG&A Expenses | $51,098 | $37,947 | $29,932 | $26,800 |
| Sales & Mktg Exp. | $912 | $336 | $226 | $175 |
| Other Operating Expenses | $0 | -$5,097 | $30,224 | $26,828 |
| Operating Expenses | $51,098 | $33,770 | $30,224 | $26,828 |
| Operating Income | $17,759 | $18,281 | $3,632 | -$2,608 |
| % Margin | 7.4% | 9% | 1.7% | -1.5% |
| Other Income/Exp. Net | -$2,974 | -$5,162 | -$866 | $123 |
| Pre-Tax Income | $14,785 | $13,119 | $4,498 | -$2,485 |
| Tax Expense | $3,202 | -$5,938 | $3,139 | $3,518 |
| Net Income | $11,405 | $18,753 | $1,359 | -$6,003 |
| % Margin | 4.7% | 9.2% | 0.6% | -3.6% |
| EPS | 3.98 | 6.51 | 0.48 | -2.15 |
| % Growth | -38.9% | 1,256.3% | 122.3% | – |
| EPS Diluted | 3.83 | 6.38 | 0.47 | -2.15 |
| Weighted Avg Shares Out | 2,862 | 2,879 | 2,824 | 2,786 |
| Weighted Avg Shares Out Dil | 2,979 | 2,938 | 2,902 | 2,786 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3,214 | $1,799 | $1,734 | $632 |
| Depreciation & Amortization | $4,759 | $3,125 | $2,867 | $2,769 |
| EBITDA | $22,758 | $18,043 | $8,160 | $916 |
| % Margin | 9.5% | 8.9% | 3.7% | 0.5% |